Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1[000000000]----1件: 66 💬
2[ALXN1210]----6件: 2, 11, 13, 50, 62, 66 💬
3[Atrasentan]1件: Atrasentan1件: Atrasentan hydrochloride 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
4[BCX9930]----4件: 62, 66, 222, 223 💬
5[Dapagliflozin]1件: Dapagliflozin1件: Dapagliflozin 💬 --1件: 66 💬
6[LNP023]----2件: 62, 66 💬
7[Metilprednisolone sodio succinato]----2件: 14, 66 💬
8[Nefecon]----1件: 66 💬
9[OMS721]----1件: 66 💬
10[Prednisone]1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬5件: 19, 66, 90, 300, 303 💬
11[RE-021]----3件: 66, 218, 222 💬
12A-623 or AMG 623----1件: 66 💬
13A07EA06----1件: 66 💬
14Abelmoschus manihot----1件: 66 💬
15ACE inhibitor----1件: 66 💬
16ACE inhibitor + statin----2件: 66, 223 💬
17ACE Inhibitor or Angiotensin receptor antagonist----1件: 66 💬
18ACE/ARB----1件: 66 💬
19ACEi----2件: 66, 224 💬
20ACEI/ARB and corticosteroids----1件: 66 💬
21Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
22Acteoside1件: Acteoside---1件: 66 💬
23ACTH (Acthar) Gel----1件: 66 💬
24Acthar 80 unit injection----1件: 66 💬
25ACTHIB - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONCINO POLVERE+1 SIRINGA PRERIEMPITA SOLVENTE 0.5 ML----2件: 62, 66 💬
26ADX-038 Dose Level 1----2件: 66, 223 💬
27ADX-038 Dose Level 2----2件: 66, 223 💬
28ADX-097----1件: 66 💬
29Aliskiren1件: Aliskiren2件: Aliskiren ,
Aliskiren fumarate 💬
1件: REN 💬 3件: Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 66, 167, 222, 223 💬
30Allopurinol1件: Allopurinol2件: Allopurinol ,
Allopurinol sodium 💬
1件: XDH 💬 4件: Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬7件: 6, 46, 57, 60, 66, 96, 97 💬
31ALN-CC5----4件: 11, 62, 66, 109 💬
32ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
33ALXN2050----3件: 11, 62, 66 💬
34Ambrisentan1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬10件: 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
35Angiotensin blockade----1件: 66 💬
36Angiotensin II1件: Angiotensin II3件: Angiotensin II ,
Angiotensin II ,
Angiotensin II acetate 💬
2件: AGTR1,
AGTR2 💬
17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
37Anti-CD19/BCMA CAR NK cells----1件: 66 💬
38Anti-CD19/BCMA CAR NK cells (KN5601)----2件: 66, 222 💬
39APL-2----6件: 2, 61, 62, 66, 222, 223 💬
40ARB----1件: 66 💬
41ARO-C3----2件: 66, 223 💬
42ARO-CFB----1件: 66 💬
43Artesunate1件: Artesunate1件: Artesunate 💬 --4件: 18, 66, 86, 96 💬
44AT-1501----1件: 66 💬
45Atacicept1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬
4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬5件: 13, 46, 49, 66, 222 💬
46Atacicept 150 mg1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬
4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
47Atacicept 25 mg1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬
4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬2件: 13, 66 💬
48Atacicept 75 mg1件: Atacicept1件: Atacicept 💬 2件: TNFSF13,
TNFSF13B 💬
4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬3件: 13, 49, 66 💬
49ATG-F----2件: 66, 223 💬
50ATRASENTAN1件: Atrasentan1件: Atrasentan hydrochloride 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 66, 218, 222 💬
51Avacopan1件: Avacopan1件: Avacopan 💬 1件: C5AR1 💬 6件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬4件: 43, 44, 66, 223 💬
52AVB-S6-500----1件: 66 💬
53Azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬
--26件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 57, 63, 65, 66, 84, 85, 93, 94, 95, 96, 97, 162, 223, 300 💬
54Azilsartan1件: Azilsartan1件: Azilsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
55Bardoxolone1件: Bardoxolone1件: Bardoxolone 💬 --7件: 66, 67, 84, 85, 86, 218, 222 💬
56Bardoxolone methyl2件: Bardoxolone,
Bardoxolone methyl
2件: Bardoxolone ,
Bardoxolone methyl 💬
--7件: 66, 67, 84, 85, 86, 218, 222 💬
57Bardoxolone methyl capsules2件: Bardoxolone,
Bardoxolone methyl
2件: Bardoxolone ,
Bardoxolone methyl 💬
--4件: 66, 67, 86, 222 💬
58BCX9930----4件: 62, 66, 222, 223 💬
59BCX9930 hydrochloride----4件: 62, 66, 222, 223 💬
60BELIMUMAB1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬17件: 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
61Benlysta----7件: 43, 48, 49, 53, 63, 66, 222 💬
62BENLYSTA® (belimumab)1件: Belimumab1件: Belimumab 💬 1件: TNFSF13B 💬 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬4件: 11, 63, 66, 222 💬
63BEXSERO - SOSPENSIONE INIETTABILE - USO INTRAMUSCOLARE - SIRINGA PRERIEMPITA (VETRO) - 0.5ML - 1 SIRINGA PRERIEMPITA CON AGO----3件: 62, 66, 223 💬
64BHV-1400----1件: 66 💬
65Bio-Kult Advanced----1件: 66 💬
66BION-1301----1件: 66 💬
67BION-1301 Multiple Doses----1件: 66 💬
68BION-1301 Single Dose----1件: 66 💬
69Blisibimod1件: Blisibimod1件: Blisibimod 💬 --5件: 43, 44, 49, 63, 66 💬
70Blisibimod Injection1件: Blisibimod1件: Blisibimod 💬 --1件: 66 💬
71Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
72BNJ441----1件: 66 💬
73BORTEZOMIB1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬19件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
74Bortezomib (Velcade®)1件: Bortezomib1件: Bortezomib 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 66 💬
75BUDESONIDE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬10件: 66, 93, 94, 95, 96, 97, 98, 223, 228, 299 💬
76C09----1件: 66 💬
77Calcitriol1件: Calcitriol1件: Calcitriol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬11件: 18, 37, 46, 49, 66, 96, 158, 223, 235, 238, 326 💬
78CCX168----6件: 43, 44, 49, 66, 109, 223 💬
79CD19 CAR-?d T cell----2件: 66, 222 💬
80CD19-targeted iNKT Cell Injection----3件: 66, 222, 223 💬
81Cemdisiran1件: Cemdisiran---6件: 11, 15, 62, 66, 109, 223 💬
82Chinese Herb Prescription Granule plus prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
83Cilazapril1件: Cilazapril2件: Cilazapril ,
Cilazapril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 66 💬
84CM313----1件: 66 💬
85CM338----1件: 66 💬
86Corticosteroid----12件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 113, 222, 223 💬
87Corticotherapy----1件: 66 💬
88Creatinine1件: Creatinine1件: Creatinine 💬 --9件: 2, 46, 49, 60, 66, 70, 96, 97, 222 💬
89Cyclophosphamid1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--2件: 66, 223 💬
90Cyclophosphamide1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬
--50件: 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
91Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --16件: 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
92Decortin H----2件: 66, 145 💬
93Dipyridamole1件: Dipyridamole1件: Dipyridamole 💬 2件: PDE4A,
PDE5A 💬
5件: Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 46, 49, 51, 66, 96, 222, 224 💬
94Drug: Atrasentan1件: Atrasentan1件: Atrasentan hydrochloride 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
95Enalapril1件: Enalapril2件: Enalapril maleate ,
Enalapril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬10件: 13, 19, 46, 57, 66, 113, 210, 222, 223, 279 💬
96ENALAPRIL VALSARTAN METHYLPREDNISONE3件: Enalapril,
Methylprednisone,
Valsartan
3件: Valsartan ,
Enalapril maleate ,
Enalapril 💬
2件: ACE,
AGTR1 💬
19件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
97EVER001----2件: 66, 222 💬
98Fecal microbiota1件: Fecal microbiota---14件: 2, 6, 13, 49, 63, 66, 93, 94, 96, 97, 99, 222, 271, 298 💬
99Fecal microbiota transplantation1件: Fecal microbiota---9件: 2, 6, 13, 63, 66, 94, 96, 97, 99 💬
100Felzartamab1件: Felzartamab---2件: 66, 222 💬
101Finerenone1件: Finerenone1件: Finerenone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬5件: 66, 218, 222, 223, 224 💬
102Fish Oil1件: Fish oil---10件: 13, 46, 49, 50, 66, 79, 96, 260, 294, 299 💬
103FOS----2件: 66, 96 💬
104Fostamatinib1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬5件: 46, 49, 61, 63, 66 💬
105Fostamatinib 100 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
106Fostamatinib 100 mg tablet1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
107Fostamatinib 150 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
108Fostamatinib 150 mg tablet1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
109Fostamatinib Disodium1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬4件: 46, 61, 63, 66 💬
110Fostamatinib Disodium tablet 100 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
111Fostamatinib Disodium tablet 150 mg1件: Fostamatinib2件: Fostamatinib ,
Fostamatinib disodium 💬
1件: SYK 💬 18件: B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagosome formation, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phagocytosis, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis 💬1件: 66 💬
112Galactose1件: Galactose1件: Galactose 💬 --4件: 66, 171, 222, 257 💬
113Gastrus----1件: 66 💬
114Genetic: PS-002----1件: 66 💬
115GlucoCorticoid----7件: 46, 49, 66, 113, 223, 228, 300 💬
116Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
117GSK1550188----5件: 11, 49, 63, 66, 222 💬
118Gut-directed budesonide and SoC1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
119HAEMOPHILUS INFLUENZAE----5件: 61, 62, 63, 66, 223 💬
120Henagliflozin1件: Henagliflozin---3件: 58, 66, 218 💬
121HIBERIX - POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE PER USO INTRAMUSCOLARE 1 FLACONCINO DI POLVERE + 1 SIRINGA PRERIEMPITA DI SOLVENTE DA 0.5 ML----5件: 61, 62, 63, 66, 223 💬
122High Dose-VIS649----1件: 66 💬
123Hormone (prednisone)1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
124HR19042 capsule----1件: 66 💬
125HR19042 Capsule, Tarpeyo®, Budenofalk®----2件: 66, 95 💬
126HR19042 Capsules----2件: 66, 95 💬
127HRS-5965----2件: 66, 223 💬
128HRS-5965 Capsules----2件: 62, 66 💬
129HRS-5965 tablets----2件: 62, 66 💬
130HS-10390----1件: 66 💬
131HS-10390 tablet----2件: 66, 222 💬
132HS-10542 High Dose----1件: 66 💬
133HS-10542 Low Dose----1件: 66 💬
134HSK39297----2件: 62, 66 💬
135HSK39297 100mgBID----1件: 66 💬
136HSK39297 200mgQD----1件: 66 💬
137HSK39297 300mgQD----1件: 66 💬
138HSK39297 50mgBID----1件: 66 💬
139Human soluble recombinant Fc-gamma receptor IIB----1件: 66 💬
140Hydroxychloroquine1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--29件: 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 89, 90, 96, 97, 107, 218, 222, 223, 224, 234, 254, 271, 298, 299 💬
141Hydroxychloroquine and SoC1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--2件: 66, 223 💬
142Hydroxychloroquine Oral Tablet1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--2件: 63, 66 💬
143Hydroxychloroquine sulfate1件: Hydroxychloroquine2件: Hydroxychloroquine sulfate ,
Hydroxychloroquine 💬
--5件: 13, 46, 48, 53, 66 💬
144Immune Suppressant----1件: 66 💬
145Immunosuppressants----1件: 66 💬
146Immunosuppressive treatment----1件: 66 💬
147Infusion of ADR-001 (Mesenchymal stem cell)----2件: 66, 223 💬
148Inhibace/Cozaar----2件: 66, 223 💬
149Intervention for incipient patients at low risk of disease progression----1件: 66 💬
150Intervention for patients at high risk of disease progression----1件: 66 💬
151Intravenous Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 66 💬
152IONIS-FB-LRx----1件: 66 💬
153Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬
1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬8件: 11, 61, 62, 63, 66, 109, 222, 223 💬
154Iptacopan hydrochloride1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬
1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬5件: 61, 63, 66, 109, 223 💬
155Irbesartan1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬6件: 57, 66, 167, 168, 222, 223 💬
156Irbesartan tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
157Irbesartan tablets (Approved in the USA. Reference listed drug Avapro) NDC # 43547-0374-031件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
158JADE101----1件: 66 💬
159KP104----4件: 49, 62, 66, 223 💬
160Leflunomide1件: Leflunomide1件: Leflunomide 💬 1件: DHODH 💬 1件: Pyrimidine metabolism 💬14件: 11, 40, 46, 49, 53, 54, 66, 107, 162, 223, 224, 270, 271, 300 💬
161Leflunomide 20 mg+prednisone 0.5mg/kg/d2件: Leflunomide,
Prednisone
2件: Prednisone ,
Leflunomide 💬
2件: DHODH,
NR3C1 💬
2件: Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬2件: 66, 223 💬
162Lisinopril1件: Lisinopril2件: Lisinopril ,
Lisinopril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬9件: 19, 46, 49, 57, 66, 67, 113, 222, 223 💬
163LNP023----7件: 61, 62, 63, 66, 109, 222, 223 💬
164LNP023 HYDROCHLORI----1件: 66 💬
165Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬
1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
166Low antigen content diet----1件: 66 💬
167Low Dose-VIS649----1件: 66 💬
168MASP-2 Antibody, OMS00620646, OMS6206461件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬1件: 66 💬
169Medium Dose-VIS649----1件: 66 💬
170Menatetrenone1件: Menatetrenone1件: Menatetrenone 💬 --2件: 66, 97 💬
171MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC----3件: 62, 66, 223 💬
172Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬
2件: PRKAA1,
PRKAA2 💬
20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬31件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
173Methylprednisolon1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬3件: 51, 66, 223 💬
174Methylprednisolone1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬51件: 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
175Methylprednisolone (drug)1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 13, 66 💬
176Methylprednisolone (MP) or prednisone (pred)2件: Methylprednisolone,
Prednisone
3件: Methylprednisolone ,
Prednisone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
177METHYLPREDNISOLONE MYLAN Générique1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
178Methylprednisolone pulse1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
179Methylprednisolone succinate1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 13, 66 💬
180Methylprednisolone(intravenously in the 1st-2nd-3rd month )1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
181Methylprednisolone(intravenously in the 1st-3rd-5th month)1件: Methylprednisolone2件: Methylprednisolone ,
Methylprednisolone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
182Methylprednisone1件: Methylprednisone---4件: 46, 66, 85, 222 💬
183Metilprednisolone sodio succinato----4件: 13, 14, 56, 66 💬
184Mezagitamab1件: Mezagitamab1件: Mezagitamab 💬 1件: CD38 💬 6件: Calcium signaling pathway, Hematopoietic cell lineage, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬3件: 63, 66, 223 💬
185MIL116----1件: 66 💬
186Mizoribine1件: Mizoribine1件: Mizoribine 💬 2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 46, 49, 51, 53, 66, 94, 222, 224 💬
187MOR03087----2件: 66, 222 💬
188MOR202----3件: 66, 222, 223 💬
189Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH)----1件: 66 💬
190MY008211A tablets----2件: 62, 66 💬
191Mycophenolat-Natrium----1件: 66 💬
192Mycophenolate mofetil2件: Mycophenolate mofetil,
Mycophenolic acid
4件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride ,
Mycophenolate sodium ,
Mycophenolic acid 💬
2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬38件: 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
193Mycophenolate mofetil (MMF)1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬8件: 13, 49, 51, 60, 65, 66, 222, 223 💬
194Mycophenolate mofetil (MMF) and SoC1件: Mycophenolate mofetil2件: Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 66, 223 💬
195Mycophenolate mofetil plus lower dose of Prednisone2件: Mycophenolate mofetil,
Prednisone
3件: Prednisone ,
Mycophenolate mofetil ,
Mycophenolate mofetil hydrochloride 💬
3件: IMPDH1,
IMPDH2,
NR3C1 💬
3件: Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬1件: 66 💬
196Mycophenolate sodium1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬
2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬6件: 49, 53, 66, 222, 223, 228 💬
197Mycophenolic acid1件: Mycophenolic acid2件: Mycophenolate sodium ,
Mycophenolic acid 💬
2件: IMPDH1,
IMPDH2 💬
2件: Drug metabolism - other enzymes, Purine metabolism 💬9件: 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
198Mycophenolic sodium----3件: 66, 222, 223 💬
199Myfortic----5件: 49, 66, 222, 223, 228 💬
200Myfortic 180mg Tablets----3件: 66, 222, 223 💬
201Myfortic 360mg Tablets----3件: 66, 222, 223 💬
202Narsoplimab1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬3件: 66, 222, 223 💬
203NEFECON----2件: 66, 223 💬
204Nefecon 16mg daily----1件: 66 💬
205Nefecon®,Ambrisentan1件: Ambrisentan1件: Ambrisentan 💬 1件: EDNRA 💬 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
206NM8074----5件: 50, 62, 66, 109, 223 💬
207Non-steroidal mineralocorticoid receptor antagonist and SoC----2件: 66, 223 💬
208NTQ5082 capsules 100 mg----1件: 66 💬
209NTQ5082 capsules 200 mg----2件: 62, 66 💬
210NTQ5082 capsules 300 mg----1件: 66 💬
211Omega-3 fatty acid ethylester90----1件: 66 💬
212Omega-3 Fatty Acid Fish Oil Supplement1件: Fish oil---1件: 66 💬
213OMS721----3件: 64, 66, 109 💬
214OMS721 (narsoplimab)1件: Narsoplimab1件: Narsoplimab 💬 1件: MASP2 💬 3件: Complement and coagulation cascades, Coronavirus disease, Staphylococcus aureus infection 💬3件: 66, 222, 223 💬
215OPL-CCL2-LPM----1件: 66 💬
216Oral prednisolone and SoC1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
217Other: Blood collection----7件: 15, 28, 36, 49, 66, 67, 223 💬
218Other: Blood test----11件: 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
219Other: continue their usual therapy----1件: 66 💬
220Other: intensive supportive care----1件: 66 💬
221Other: Optimized Supportive Care----1件: 66 💬
222Other: urine sample----7件: 46, 49, 66, 177, 223, 240, 335 💬
223Other: Vehicle (D5W or saline)----1件: 66 💬
224Over-encapsulated 150 mg Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬1件: 66 💬
225Over-encapsulated Irbesartan Tablets1件: Irbesartan1件: Irbesartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬2件: 66, 222 💬
226Paricalcitol1件: Paricalcitol1件: Paricalcitol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298 💬
227Plasma exchange (PE)----6件: 11, 13, 64, 66, 221, 223 💬
228PNEUMOVAX – Soluzione iniettabile in siringa preriempita da 0,5 ml----2件: 62, 66 💬
229Potassium1件: Potassium1件: Potassium 💬 --17件: 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
230Povetacicept1件: Povetacicept1件: Povetacicept 💬 1件: TNFRSF13B 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Primary immunodeficiency 💬5件: 11, 61, 63, 66, 222 💬
231Prednisolon----11件: 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
232PREDNISOLONE1件: Prednisolone1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬48件: 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
233Prednisolone plus Cyclophosphamide2件: Cyclophosphamide,
Prednisolone
3件: Cyclophosphamide ,
Prednisolone ,
Cyclophosphamide 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
234Prednisone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬58件: 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
235Prednisone + Inhibace/Cozaar1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
236Prednisone 5 mg1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 46, 66 💬
237Prednisone acetate3件: Acetate,
Prednisone,
Prednisone acetate
2件: Prednisone ,
Prednisone acetate 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬9件: 35, 40, 46, 49, 63, 66, 162, 222, 224 💬
238Prednisone alone1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 11, 66 💬
239Prednisone and cyclophosphamide2件: Cyclophosphamide,
Prednisone
3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
240PREDNISONE ARROW 20mg1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
241PREDNISONE ARROW 5 mg1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
242Prednisone in full dose1件: Prednisone1件: Prednisone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
243Prednisone or Prednisolone2件: Prednisolone,
Prednisone
2件: Prednisolone ,
Prednisone 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 84 💬
244Prednisone plus cyclophosphamide2件: Cyclophosphamide,
Prednisone
3件: Cyclophosphamide ,
Prednisone ,
Cyclophosphamide 💬
1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 66 💬
245Probiotics combined with enteric-coated budesonide capsule1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 66, 223 💬
246Probucol1件: Probucol1件: Probucol 💬 --4件: 21, 66, 79, 223 💬
247Proline1件: Proline1件: Proline 💬 --3件: 66, 94, 97 💬
248ProTectis----1件: 66 💬
249QT-219CX----3件: 51, 66, 222 💬
250R935788----4件: 46, 61, 63, 66 💬
251Ramipril1件: Ramipril1件: Ramipril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬10件: 46, 49, 57, 66, 67, 113, 218, 222, 223, 257 💬
252Rapamune----8件: 2, 60, 66, 67, 84, 158, 278, 280 💬
253RAS 2410----1件: 66 💬
254RAS inhibitor----1件: 66 💬
255RAVULIZUMAB1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 2, 11, 13, 50, 62, 66, 109, 224 💬
256RC18 160mg----3件: 11, 13, 66 💬
257RC18 240mg----2件: 13, 66 💬
258RE-021----3件: 66, 218, 222 💬
259Reh-acteoside1件: Acteoside---1件: 66 💬
260Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)----1件: 66 💬
261RG002C0106----1件: 66 💬
262RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
263SC0062 high dose----1件: 66 💬
264SC0062 low dose----1件: 66 💬
265SC0062 medium dose----1件: 66 💬
266SC0062 strength 10mg----1件: 66 💬
267SCTC21C----1件: 66 💬
268Sefaxersen (RO7434656)----1件: 66 💬
269SGB-9768----2件: 66, 223 💬
270Shenqi Yishen Granules----1件: 66 💬
271SHR-2010 Injection----1件: 66 💬
272SHR-2173 injection----5件: 11, 49, 63, 66, 222 💬
273Sibeprenlimab1件: Sibeprenlimab1件: Sibeprenlimab 💬 1件: TNFSF13 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬1件: 66 💬
274Simulect----3件: 66, 97, 223 💬
275Simvastatin1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬22件: 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
276Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬46件: 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
277Sirolimus (study drug)+ACE inhibitor + statin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬2件: 66, 223 💬
278SLN12140----2件: 62, 66 💬
279SM101----3件: 49, 63, 66 💬
280SMOFKABIVEN - EMULSIONE PER INFUSIONE SENZA ELETTROLITI 1 SACCA BIOFINE MULTICOMPARTIMENTATE DA 493 ML----1件: 66 💬
281SoC defined as maximal labelled or tolerated dose of angiotensin-converting enzyme inhibitor/ angiotensin receptor blocker (ACEi/ARB) & steady dose of sodium-glucose cotransporter-2 inhibitor (SGLT2i)----2件: 66, 223 💬
282SOLU MEDROL----2件: 56, 66 💬
283SOLU MEDROL - 1000 MG/16 ML POLVERE E SOLVENTE PER SOLUZIONE INIETTABILE 1 FLACONE DI POLVERE DA 1000 MG+ 1 FLACONE SOLVENTE DA 16 ML----1件: 66 💬
284SPARSENTAN1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬
18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 66, 218, 222, 223 💬
285Sparsentan compresse1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬
18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
286Sparsentan tablets/Over-encapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬
18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
287Sparsentan tablets/over-encapsulated Spasenten tablets1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬
18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
288Sparsentan tablets/Overencapsulated Sparsentan tablets1件: Sparsentan1件: Sparsentan 💬 2件: AGTR1,
EDNRA 💬
18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 66 💬
289Steroids----7件: 46, 50, 51, 63, 66, 96, 97 💬
290Steroids plus azathioprine1件: Azathioprine2件: Azathioprine ,
Azathioprine sodium 💬
--1件: 66 💬
291Supportive and immunosuppressive therapy----1件: 66 💬
292Supportive therapy----2件: 66, 223 💬
293Supportive therapy with: ACE-inhibitor / ARB / Statin----1件: 66 💬
294Tacrolimus1件: Tacrolimus2件: Tacrolimus ,
Tacrolimus 💬
5件: PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
33件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬37件: 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
295Tailored diet----1件: 66 💬
296TARPEYO 4 MG Delayed Release Oral Capsule----1件: 66 💬
297TARPEYO®----1件: 66 💬
298Telitacicept1件: Telitacicept---14件: 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
299Telitacicept 160mg1件: Telitacicept---3件: 49, 66, 223 💬
300Telitacicept 240mg1件: Telitacicept---1件: 66 💬
301Telmisartan1件: Telmisartan1件: Telmisartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 6, 57, 66, 67, 222 💬
302Tetracycline1件: Tetracycline2件: Tetracycline ,
Tetracycline hydrochloride 💬
--5件: 13, 46, 53, 66, 97 💬
303The Yi-Qi-Qing-Jie herbal compound----1件: 66 💬
304Tofacitinib1件: Tofacitinib2件: Tofacitinib citrate ,
Tofacitinib 💬
4件: JAK1,
JAK2,
JAK3,
TYK2 💬
39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬23件: 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
305Tonsillectomy----1件: 66 💬
306Tripterygium wilfordii (TW)----2件: 66, 222 💬
307UCAR T-cell----7件: 11, 13, 14, 49, 51, 66, 222 💬
308Ultomiris----7件: 2, 11, 13, 50, 62, 66, 109 💬
309Ultomiris 300 mg/30 ml----1件: 66 💬
310VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----5件: 61, 62, 63, 66, 223 💬
311VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----5件: 61, 62, 63, 66, 223 💬
312VACCINO PNEUMOCOCCICO----2件: 62, 66 💬
313VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----5件: 61, 62, 63, 66, 223 💬
314Valsartan1件: Valsartan1件: Valsartan 💬 1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬11件: 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬
315VIS649----1件: 66 💬
316VT-001----1件: 66 💬
317Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬
2件: NQO1,
VKORC1 💬
5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬15件: 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
318Water1件: Water1件: Water 💬 --36件: 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
319WM (Shentong Granules)----1件: 66 💬
320XH-S003 Capsule----2件: 62, 66 💬
321YKST02----2件: 49, 66 💬
322Zigakibart1件: Zigakibart1件: Zigakibart 💬 1件: TNFSF13 💬 3件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Rheumatoid arthritis 💬2件: 66, 223 💬
323 LNP023 HYDROCHLORIDE SALT----7件: 61, 62, 63, 66, 109, 222, 223 💬